Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
about
Nicotinic receptors in non-human primates: Analysis of genetic and functional conservation with humans.Can Functional Magnetic Resonance Imaging Improve Success Rates in CNS Drug Discovery?Decision-making in the pharmaceutical industry: analysis of entrepreneurial risk and attitude using uncertain information
P2860
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@ast
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@en
type
label
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@ast
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@en
prefLabel
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@ast
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@en
P2860
P921
P1433
P1476
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
@en
P2093
J Fred Pritchard
P2860
P2888
P356
10.1186/1471-2202-9-S3-S1
P478
P5008
P577
2008-12-10T00:00:00Z
P6179
1050423986